Analyst firms · Morgan Stanley · ZION

Morgan Stanley ZION price target and rating history

Zions Bancorporation N.A. (ZION) · Finance

Morgan Stanley rates Zions Bancorporation N.A. (ZION) Underweight with a $77 price target, as of its latest action on Sep 8, 2026. It has published 5 rating actions on ZION since December 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a ZION price target in the last 12 months, the median target is $75. Morgan Stanley's $77 is 3% above that.

Current rating
Underweight
Price target
$77
Median target, all firms
$75
Actions on ZION
5

Morgan Stanley price target on ZION

$77$55$322023202420252026
Morgan Stanley price target on ZION, each point a stated target, December 2022 to September 2026.

Every Morgan Stanley rating on ZION

How other firms rate ZION

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Robert W. BairdOutperform$75Oct 15, 2026
UBSBuy$78Sep 14, 2026
Morgan StanleyUnderweight$77Sep 8, 2026
Evercore ISIIn-line$68Jul 23, 2026
StephensOverweightJun 15, 2026
Brean CapitalNeutralMar 12, 2026
JefferiesBuy$60Nov 19, 2025

Questions about Morgan Stanley and ZION

What is Morgan Stanley's price target for ZION?
Morgan Stanley's latest stated price target for Zions Bancorporation N.A. (ZION) is $77, from its action on Sep 8, 2026.
What is Morgan Stanley's rating on ZION?
Morgan Stanley rates ZION Underweight, a bearish rating, as of Sep 8, 2026.
When did Morgan Stanley last change its view on ZION?
On Sep 8, 2026, Morgan Stanley downgrades to Underweight from Overweight, price target $77.
How does Morgan Stanley's ZION target compare with other analysts?
Across 5 firms with a ZION price target in the last 12 months, the median target is $75. Morgan Stanley's $77 is 3% above that.

More ZION rating histories

All Morgan Stanley ratingsZION news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.